Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 08:02 ET | Source: Quantum BioPharma

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a...
February 03, 2026 11:00 ET | Source: Rafferty Domnick Cunningham & Yaffa

Rafferty Domnick Cunningham & Yaffa to Try Palm Beach County Medical Malpractice Case Against South Florida Anesthesia and Affiliated Providers

Rafferty Domnick Cunningham & Yaffa announce they will try a medical malpractice case. Sean C. Domnick and Nicole Kruegel will be trying the case.
January 06, 2026 11:50 ET | Source: Dubin Research and Consulting

Distinguished Trial Attorney Joseph Conza Brings 30 Years of Courtroom Expertise to DRC as a Director of Litigation Strategy

Dubin Research & Consulting (“DRC”) hires experienced trial attorney Joseph (“Joe”) Conza, Esq., as a Director of Litigation Strategy.
December 17, 2025 08:45 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid...
December 16, 2025 15:07 ET | Source: Blank Rome LLP

Blank Rome Welcomes Mitchell S. Goldberg, Immediate Past Chief Judge of the U.S. District Court for the Eastern District of Pennsylvania in Philadelphia

Philadelphia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Blank Rome LLP is proud to announce the Honorable Mitchell S. Goldberg, most recently Chief Judge of the United States District Court for the Eastern...
September 04, 2025 11:23 ET | Source: Dubin Research and Consulting

Jury Awards $425.7 Million to Plaintiffs in California Trial Against Google

DRC congratulates Rodriguez v. Google trial team clients on $425.7 Million jury verdict against Google in privacy class action
August 14, 2025 08:30 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

BOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its...
August 11, 2025 09:00 ET | Source: Tiziana Life Sciences Ltd.

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
July 21, 2025 07:30 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Announces Oversubscribed $175 Million Private Placement

SAB BIO Announces Oversubscribed $175 Million Private Placement
June 13, 2025 10:30 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...